TrialJournal of the American Heart Association2015

Infusion of Reconstituted High-Density Lipoprotein, CSL112, in Patients With Atherosclerosis: Safety and Pharmacokinetic Results From a Phase 2a Randomized Clinical Trial.

Pierluigi Tricoci et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.